Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture
Lab / animal
OA: closed
CC0
⤵ 85 in-corpus citations
AI-generated summary
Dienogest was found to decrease aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells grown in spheroid culture.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To determine the effect of dienogest (DNG) on the expression of aromatase and cyclooxygenase-2 (COX-2) and the production of prostaglandin E(2) (PGE(2)) in human endometriotic stromal cells (ESCs).
DESIGN: Experimental study in vitro.
SETTING: University hospital.
PATIENT(S): Seventeen patients with ovarian endometrioma.
INTERVENTION(S): ESCs from chocolate cyst linings of ovaries were treated with DNG.
MAIN OUTCOME MEASURE(S): Expression of aromatase and COX-2 evaluated in spheroid cultures of human ESCs by real-time quantitative polymerase chain-reaction and immunocytochemistry, production of PGE(2) quantified by enzyme-linked immunosorbent assay (ELISA), and nuclear factor kappa B (NF-κB) DNA-binding examined by ELISA and immunocytochemistry.
RESULT(S): The pharmaceutical actions of DNG on the expression of aromatase and COX-2 and the production of PGE(2) were examined using spheroid cultures of human ESCs. More aromatase, COX-2, and PGE(2) were expressed in spheroid cultures than in conventional ESCs monolayers. In the spheroid cultures, DNG (10(-7) M) and progesterone (10(-7) M) inhibited the expression of aromatase, COX-2, and PGE(2). DNG also inhibited NF-κB DNA-binding activity and reduced the immunocytochemical protein expression of aromatase, COX-2, and NF-κB p50 nuclear localization.
CONCLUSION(S): Because DNG inhibits aromatase and COX-2 expression as well as PGE(2) production in ESCs, these pharmacologic features might contribute to a therapeutic effect of DNG on endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (28)
- Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system via openalex
- Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Endometriosis via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis via openalex
- High-dose pilot study with the novel progestogen dienogestin patients with endometriosis via openalex
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells via openalex
- The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro via openalex
- Tumor necrosis factor-alpha-induced cyclooxygenase-2 overexpression in eutopic endometrium of women with endometriosis by stromal cell culture through nuclear factor-kappaB activation via openalex
- W6723391054 via openalex
- W1989696800 via openalex
- W1992453495 via openalex
- W2001831389 via openalex
- W2010311608 via openalex
- W2016744320 via openalex
- W2022658482 via openalex
- W2058312109 via openalex
- W2068397002 via openalex
- W2101417341 via openalex
- W2497131907 via openalex
- W4285719527 via openalex
- W6605145255 via openalex
- doi:10.2165/00002512-200421130-00004 via openalex
Cited by (50)
- Macrophage-centered immune-fibrotic persistence in endometriosis and adenomyosis: non-hormonal immunopharmacological targets 2026
- The Therapeutic Role of Dienogest in Endometriosis-Associated Pain: From Basics to Clinics 2026
- Postmenopausal endometriosis: current evidence and clinical challenges in diagnosis and treatment 2026
- Drospirenone promotes apoptosis in ectopic but inhibits proliferation in eutopic human endometrial stromal cells 2026
- Aktuelle medikamentöse Ansätze bei Endometriose 2026
- Impact of endometrioma management strategies on ovarian reserve over the follow-up period, a prospective longitudinal study 2025
- WITHDRAWN: Effects of Deinorgestrel Treatment of Endometriosis on Ovarian Function, Inflammatory Factors, and Pregnancy Rate in Patients 2025
- Hormonal imbalance-mediated immune inflammation in endometrial decidualization disorder 2025
- Clinical efficacy of dienogest against endometriomas with a maximum diameter of ≥4 cm 2024
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Genome-Wide Gene Expression Profiling Reveals the Direct Effect of Dienogest on Ovarian Endometriotic Stromal Cells 2023
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Dienogest therapy: a window of opportunity for endometriosis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Low-Nutrient Environment-Induced Changes in Inflammation, Cell Proliferation, and PGC-1α Expression in Stromal Cells with Ovarian Endometriosis 2022
- Efficacy of Low-Dose Estrogen-Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis 2022
- Hypoxia-hindered methylation of PTGIS in endometrial stromal cells accelerates endometriosis progression by inducing CD16- NK-cell differentiation 2022
- Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism 2022
- Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis 2021
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Three-Dimensional Biofabrication Models of Endometriosis and the Endometriotic Microenvironment 2020
- Three-Dimensional Biofabrication Models of Endometriosis and the Endometriotic Microenvironment 2020
- The scar constituent Collagen I triggers coordinated collective migration and invasion in a 3D spheroid model of early endometriotic lesions 2020
- A progestin isn't a progestin: dienogest for endometriosis as a blueprint for future research - Review as a contribution for discussion 2020
- Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction 2019
- Suppressive Effects of Ursolic Acid on Human Endometriotic Stromal Cells Survival 2019
- Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis 2019
- Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases 2018
- What do we know about endometrioid cysts today? 2018
- Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis 2018
- Aromatase as a target for treating endometriosis 2018
- Ovarian reserve evaluation after laparoscopic cyst enucleation, depending on applied haemostasis technique and with particular consideration of endometrial cysts 2018
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:09:44.076416+00:00
License: CC0
· commercial use OK